Stains & CD markers
CD270-279


Last author update: 13 November 2019
Last staff update: 17 July 2024

Copyright: 2019-2024, PathologyOutlines.com, Inc.

Nat Pernick, M.D.
Page views in 2023: 1,249
Page views in 2024 to date: 85
Table of Contents
CD270 | CD272 / BTLA | CD273 | CD274 | CD278 | CD279
Cite this page: Pernick N. CD270-279. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/cdmarkerscd270to279.html. Accessed December 4th, 2024.
CD270
  • Also known as tumor necrosis factor receptor superfamily member 14 (TNFRSF14), Herpesvirus entry mediator (HVEM) (GeneCards)
  • Ligand to B and T lymphocyte attenuator (BTLA, Diagn Pathol 2012;7:142)
  • Acts as receptor for Herpes simplex virus (Virology 2014;448:185)
  • Recurrent mutations associated with pediatric follicular lymphoma (Haematologica 2013;98:1237)
  • Acquired mutations associated with worse prognosis in follicular lymphoma (Cancer Res 2010;70:9166)
  • No uses for pathologists at this time
  • Positive staining: T cells (constitutive or induced)
CD272 / BTLA
CD273
  • Programmed cell death ligand 2; also called B7DC
  • Involved in the costimulatory signal, essential for T lymphocyte proliferation and interferon gamma production
  • Found in the plasma membrane
CD274
CD278
  • Also called ICOS
  • Enhances basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction and effective help for antibody secretion by B-cells
  • Essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens
  • Plays a critical role in CD40-mediated class switching of immunoglobin isotypes
  • A type I membrane protein
  • Defects cause ICOS deficiency (OMIM 607594), a form of common variable immunodeficiency characterized by recurrent bacterial infections of the respiratory and digestive tracts, but without splenomegaly, autoimmune disease, sarcoid-like granulomas, overt T cell immunodeficiency
  • Present in: activated T cells, tonsillar T cells, fetal and newborn thymic medulla
  • Reference: Swiss-Prot entry
CD279
Back to top
Image 01 Image 02